{
  "nctId": "NCT02774616",
  "briefTitle": "BIO|MASTER.Ilivia Family / Plexa",
  "officialTitle": "BIO|MASTER.Ilivia Family / Plexa",
  "protocolDocument": {
    "nctId": "NCT02774616",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2016-11-14",
    "uploadDate": "2018-07-18T09:17",
    "size": 3456388,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02774616/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NON_RANDOMIZED",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 292,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2016-06",
    "completionDate": "2018-03",
    "primaryCompletionDate": "2017-12",
    "firstSubmitDate": "2016-05-13",
    "firstPostDate": "2016-05-17"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Standard indication for ICD or CRT-D therapy according to clinical practice\n* De novo implantation or upgrade/exchange (group A only) from existing ICD, CRT-D or pacemaker implant\n* Patient is able to understand the nature of the clinical investigation and provides written informed consent\n* Patient is able and willing to complete all routine study visits at the investigational site\n* Patient accepts Home Monitoring concept\n* Age â‰¥ 18 years\n\nExclusion Criteria:\n\n* Contraindication to ICD or CRT-D therapy, respectively\n* For CRT-D patients in group A only: physician not willing to activate MultiPole Pacing in the patient\n* Cardiac surgical procedure planned within 6 months after implantation (including also interventional procedures like ablation, valve replacement etc.). Procedures to occur during or prior to implantation are not exclusionary.\n* Expected to receive heart transplant or ventricular assist device within 6 months\n* Life expectancy less than 6 months\n* Participation in any other interventional clinical investigation\n* Pregnant or breastfeeding at time of enrollment",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Ilivia Family Related SADE-free Rate Through 3 Months",
        "description": "This endpoint measures the percentage of patients without serious adverse device effect (SADE) related to the ICD device",
        "timeFrame": "3 months"
      },
      {
        "measure": "Plexa Related SADE-free Rate Through 6 Months",
        "description": "This endpoint measures the percentage of patients without serious adverse device effect (SADE) related to the \"Plexa\" lead",
        "timeFrame": "6 months"
      }
    ],
    "secondary": [
      {
        "measure": "Percentage of Patients With Successful Fast Ventricular Arrhythmia Conversion by ATP One-shot at 6-month Follow-up",
        "description": "Of all patients with spontaneous ventricular arrhythmia detected in the VF zone, and treated by \"ATP-one-shot\", the percentage of patients with at least one successful termination will be determined",
        "timeFrame": "6 months"
      },
      {
        "measure": "Rate of Appropriate Right Ventricular Sensing at 3-month Follow-up",
        "description": "The investigator is asked whether the sensing function of the Pleaxa lead in the right ventricle is appropriate",
        "timeFrame": "3 months"
      },
      {
        "measure": "Rate of Appropriate Right Ventricular Pacing at the 3 Months Follow-up",
        "description": "The investigator is asked whether the pacing function of the Pleaxa lead in the right ventricle is appropriate",
        "timeFrame": "3 months"
      }
    ],
    "other": []
  },
  "realComplexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 6,
      "exclusionCount": 7,
      "totalCount": 13
    },
    "endpoints": {
      "primaryCount": 2,
      "secondaryCount": 3,
      "otherCount": 0,
      "totalCount": 5
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 61,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-21T22:32:39.982Z",
  "dataSource": "ClinicalTrials.gov API v2"
}